| Prev Close | 54.54 |
| Open | 54.83 |
| Day Low/High | 54.54 / 55.34 |
| 52 Wk Low/High | 51.72 / 82.15 |
| Volume | 7.15M |
| Avg Volume | 11.27M |
CVS Health Corp. (CVS)
54.66
0.12
0.22
NYSE : Retail Trade
| Exchange | NYSE |
| Shares Outstanding | 1.30B |
| Market Cap | 70.37B |
| EPS | -0.60 |
| P/E Ratio | N/A |
| Div & Yield | 2.00 (3.66%) |
Latest News
Make Big Money: Think Like an Insider
Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.
Jim Cramer: With Biden the Democratic Favorite, These Stocks Are Front-Runners
These managed care stocks can withstand China, politics and a slowdown in the economy.
Real Money Post-Industrial Average Leaves Major Indices in the Dust
RMPIA outperformed once gain during April.
A Review of the Regulatory Hurdles Remaining for the CVS Aetna Acquisition
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
'Medicare for All' Efforts Should Rightfully Weigh on CVS Shareholder Minds
As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.
Here Are My Trade Ideas for CVS Stock
CVS Health is still a cash flow machine.
CVS Stock Surges as Aetna Acquisition Comes Into View
CVS is setting up an anticipated new stock trajectory for investors.
3 Top Healthcare Stocks Ripe For the Buying
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Chart of the Day: UNH's Universal Healthcare Comments Sting Sector
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
Jim Cramer: When the Death Star Strikes
It has become almost too onerous to own something that could be in Amazon's crosshairs.
Jim Cramer: Betting That the Next Pieces of News Will Be Very Stock Heartening
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
Tesla's Debacle and 3 More Stocks to Carefully Watch
Look at the entirety of your portfolio and make sure there are no earnings blow-ups coming from the companies that you own.
Lunch Time Reading
As I sit down to eat some lunch and gather my thoughts for the afternoon, here are some of the items I'll be reading up on: · Outgoing FDA chief Scott Gottlieb raises 'concern' over Walgreens Boosts Alliance, Inc. , and CVS Health Corp. selling CBD...
Jim Cramer: Lyft Was Cooler Than Being Cool Until It Turned Ice Cold
I have had to think long and hard about Lyft, the stock, not the ride-sharing company.
Shift to CBD From Cigarettes Isn't Enough to Sustain Walgreens Stock
In fact, the de-emphasizing of cigarettes was blamed for declining same store sales.
Walgreens Market Outlook, ePharmacy Acceleration Pummel Pharmacy Stocks
The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.
Is Opportunity Knocking as Walgreens Stock Suffers a Bloodletting?
Might this be the bottom? It might.
Walgreens Stock Falls After Earnings, Guidance Disappoint
Walgreens weak guidance is sending shares plummeting on Tuesday.
Gold Stocks Are Positive on a Negative Day: Here Are My 2 Favorites
While today's action isn't attractive, we were ripe for a little profit-taking.
CVS or Walgreens: Which Is the Better Dividend Stock?
While the two companies seem very similar on the surface, CVS and Walgreens are different stocks for different types of investors.
Jim Cramer: The Ultimate Case for the Leap of Taste Not Faith
I think sometimes the best way to parse the temperament is to go over the most obviously 'wrong' moves and address why they might not be wrong at all.
